HEADER OXIDOREDUCTASE 30-OCT-06 2NQ8 TITLE MALARIAL ENOYL ACYL ACP REDUCTASE BOUND WITH INH-NAD ADDUCT COMPND MOL_ID: 1; COMPND 2 MOLECULE: ENOYL-ACYL CARRIER REDUCTASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: ENOYL-ACP REDUCTASE; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: ENOYL-ACYL CARRIER REDUCTASE; COMPND 8 CHAIN: C, D; COMPND 9 SYNONYM: ENOYL-ACP REDUCTASE; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PLASMODIUM FALCIPARUM; SOURCE 3 ORGANISM_COMMON: MALARIA PARASITE P. FALCIPARUM; SOURCE 4 ORGANISM_TAXID: 5833; SOURCE 5 GENE: FABI; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: PLASMODIUM FALCIPARUM; SOURCE 10 ORGANISM_COMMON: MALARIA PARASITE P. FALCIPARUM; SOURCE 11 ORGANISM_TAXID: 5833; SOURCE 12 GENE: FABI; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS PFENR; INH; MALARIA, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR J.S.FREUNDLICH,M.YU,E.LUCUMI,M.KUO,H.C.TSAI,J.C.VALDERRAMOS, AUTHOR 2 L.KARAGYOZOV,W.R.JACOBS JR.,G.A.SCHIEHSER,D.A.FIDOCK,D.P.JACOBUS, AUTHOR 3 J.C.SACCHETTINI REVDAT 5 13-JUL-11 2NQ8 1 VERSN REVDAT 4 24-FEB-09 2NQ8 1 VERSN REVDAT 3 20-NOV-07 2NQ8 1 JRNL REVDAT 2 31-JUL-07 2NQ8 1 JRNL REVDAT 1 17-JUL-07 2NQ8 0 JRNL AUTH J.S.FREUNDLICH,F.WANG,H.C.TSAI,M.KUO,H.M.SHIEH,J.W.ANDERSON, JRNL AUTH 2 L.J.NKRUMAH,J.C.VALDERRAMOS,M.YU,T.R.KUMAR,S.G.VALDERRAMOS, JRNL AUTH 3 W.R.JACOBS,G.A.SCHIEHSER,D.P.JACOBUS,D.A.FIDOCK, JRNL AUTH 4 J.C.SACCHETTINI JRNL TITL X-RAY STRUCTURAL ANALYSIS OF PLASMODIUM FALCIPARUM ENOYL JRNL TITL 2 ACYL CARRIER PROTEIN REDUCTASE AS A PATHWAY TOWARD THE JRNL TITL 3 OPTIMIZATION OF TRICLOSAN ANTIMALARIAL EFFICACY JRNL REF J.BIOL.CHEM. V. 282 25436 2007 JRNL REFN ISSN 0021-9258 JRNL PMID 17567585 JRNL DOI 10.1074/JBC.M701813200 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 70.15 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 93.5 REMARK 3 NUMBER OF REFLECTIONS : 24177 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.216 REMARK 3 FREE R VALUE : 0.272 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 2379 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4578 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 104 REMARK 3 SOLVENT ATOMS : 160 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 39.90 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.59000 REMARK 3 B22 (A**2) : 2.59000 REMARK 3 B33 (A**2) : -5.17900 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.28 REMARK 3 ESD FROM SIGMAA (A) : 0.26 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.38 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.36 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.50 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2NQ8 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-NOV-06. REMARK 100 THE RCSB ID CODE IS RCSB040169. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 121 REMARK 200 PH : 5.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : BRUKER AXS MICROSTAR REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : BRUKER SMART 2000 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : PROTEUM PLUS REMARK 200 DATA SCALING SOFTWARE : PROTEUM PLUS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 24589 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 70.150 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.8 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.63 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.8 REMARK 200 DATA REDUNDANCY IN SHELL : 15.18 REMARK 200 R MERGE FOR SHELL (I) : 0.27400 REMARK 200 R SYM FOR SHELL (I) : 0.27700 REMARK 200 FOR SHELL : 0.710 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: 1NHD REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.51 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.76 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2.4M (NH4)2SO4, 0.1M MES ( PH 5.6), REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 289K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 41.42250 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 65.94950 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 65.94950 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 62.13375 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 65.94950 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 65.94950 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 20.71125 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 65.94950 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 65.94950 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 62.13375 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 65.94950 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 65.94950 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 20.71125 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 41.42250 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL ASSEMBLY IS A TERAMER GENERATED FROM THE REMARK 300 DIMER IN THE ASYMMETRIC UNIT REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: OCTAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: OCTAMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 35510 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 39130 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -222.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.000000 -1.000000 0.000000 131.89900 REMARK 350 BIOMT2 2 -1.000000 0.000000 0.000000 131.89900 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 41.42250 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 132 -56.94 -29.24 REMARK 500 LYS A 155 14.93 -53.55 REMARK 500 ALA A 169 6.73 -69.00 REMARK 500 LYS A 185 -35.95 -36.57 REMARK 500 ASN A 188 -70.51 -43.60 REMARK 500 LEU A 226 -55.92 -27.70 REMARK 500 HIS A 268 -13.44 -49.84 REMARK 500 SER A 317 -106.65 -98.41 REMARK 500 ARG A 318 -38.96 -149.38 REMARK 500 ASN A 324 101.17 29.57 REMARK 500 ASP B 107 164.70 166.50 REMARK 500 ASP B 154 -59.90 -23.65 REMARK 500 LYS B 155 37.10 -67.67 REMARK 500 ASP B 156 -23.67 64.93 REMARK 500 LYS B 157 155.43 -45.85 REMARK 500 MET B 159 142.71 -30.21 REMARK 500 ALA B 169 2.32 -65.73 REMARK 500 ASN B 210 15.75 -142.38 REMARK 500 ASN B 324 101.45 53.83 REMARK 500 THR C 367 142.43 49.04 REMARK 500 ASP C 414 29.69 -148.87 REMARK 500 PHE C 421 -72.33 -94.28 REMARK 500 THR D 367 148.92 51.98 REMARK 500 ASP D 414 35.24 -150.40 REMARK 500 PRO D 423 -141.62 -67.99 REMARK 500 ASP D 424 -74.06 -144.30 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZID B 450 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZID A 550 DBREF 2NQ8 A 97 325 UNP Q9BH77 Q9BH77_PLAFA 97 325 DBREF 2NQ8 B 97 325 UNP Q9BH77 Q9BH77_PLAFA 97 325 DBREF 2NQ8 C 366 425 UNP Q9BH77 Q9BH77_PLAFA 366 425 DBREF 2NQ8 D 366 425 UNP Q9BH77 Q9BH77_PLAFA 366 425 SEQRES 1 A 229 GLU ASP ILE CYS PHE ILE ALA GLY ILE GLY ASP THR ASN SEQRES 2 A 229 GLY TYR GLY TRP GLY ILE ALA LYS GLU LEU SER LYS ARG SEQRES 3 A 229 ASN VAL LYS ILE ILE PHE GLY ILE TRP PRO PRO VAL TYR SEQRES 4 A 229 ASN ILE PHE MET LYS ASN TYR LYS ASN GLY LYS PHE ASP SEQRES 5 A 229 ASN ASP MET ILE ILE ASP LYS ASP LYS LYS MET ASN ILE SEQRES 6 A 229 LEU ASP MET LEU PRO PHE ASP ALA SER PHE ASP THR ALA SEQRES 7 A 229 ASN ASP ILE ASP GLU GLU THR LYS ASN ASN LYS ARG TYR SEQRES 8 A 229 ASN MET LEU GLN ASN TYR THR ILE GLU ASP VAL ALA ASN SEQRES 9 A 229 LEU ILE HIS GLN LYS TYR GLY LYS ILE ASN MET LEU VAL SEQRES 10 A 229 HIS SER LEU ALA ASN ALA LYS GLU VAL GLN LYS ASP LEU SEQRES 11 A 229 LEU ASN THR SER ARG LYS GLY TYR LEU ASP ALA LEU SER SEQRES 12 A 229 LYS SER SER TYR SER LEU ILE SER LEU CYS LYS TYR PHE SEQRES 13 A 229 VAL ASN ILE MET LYS PRO GLN SER SER ILE ILE SER LEU SEQRES 14 A 229 THR TYR HIS ALA SER GLN LYS VAL VAL PRO GLY TYR GLY SEQRES 15 A 229 GLY GLY MET SER SER ALA LYS ALA ALA LEU GLU SER ASP SEQRES 16 A 229 THR ARG VAL LEU ALA TYR HIS LEU GLY ARG ASN TYR ASN SEQRES 17 A 229 ILE ARG ILE ASN THR ILE SER ALA GLY PRO LEU LYS SER SEQRES 18 A 229 ARG ALA ALA THR ALA ILE ASN LYS SEQRES 1 B 229 GLU ASP ILE CYS PHE ILE ALA GLY ILE GLY ASP THR ASN SEQRES 2 B 229 GLY TYR GLY TRP GLY ILE ALA LYS GLU LEU SER LYS ARG SEQRES 3 B 229 ASN VAL LYS ILE ILE PHE GLY ILE TRP PRO PRO VAL TYR SEQRES 4 B 229 ASN ILE PHE MET LYS ASN TYR LYS ASN GLY LYS PHE ASP SEQRES 5 B 229 ASN ASP MET ILE ILE ASP LYS ASP LYS LYS MET ASN ILE SEQRES 6 B 229 LEU ASP MET LEU PRO PHE ASP ALA SER PHE ASP THR ALA SEQRES 7 B 229 ASN ASP ILE ASP GLU GLU THR LYS ASN ASN LYS ARG TYR SEQRES 8 B 229 ASN MET LEU GLN ASN TYR THR ILE GLU ASP VAL ALA ASN SEQRES 9 B 229 LEU ILE HIS GLN LYS TYR GLY LYS ILE ASN MET LEU VAL SEQRES 10 B 229 HIS SER LEU ALA ASN ALA LYS GLU VAL GLN LYS ASP LEU SEQRES 11 B 229 LEU ASN THR SER ARG LYS GLY TYR LEU ASP ALA LEU SER SEQRES 12 B 229 LYS SER SER TYR SER LEU ILE SER LEU CYS LYS TYR PHE SEQRES 13 B 229 VAL ASN ILE MET LYS PRO GLN SER SER ILE ILE SER LEU SEQRES 14 B 229 THR TYR HIS ALA SER GLN LYS VAL VAL PRO GLY TYR GLY SEQRES 15 B 229 GLY GLY MET SER SER ALA LYS ALA ALA LEU GLU SER ASP SEQRES 16 B 229 THR ARG VAL LEU ALA TYR HIS LEU GLY ARG ASN TYR ASN SEQRES 17 B 229 ILE ARG ILE ASN THR ILE SER ALA GLY PRO LEU LYS SER SEQRES 18 B 229 ARG ALA ALA THR ALA ILE ASN LYS SEQRES 1 C 60 TYR THR PHE ILE ASP TYR ALA ILE GLU TYR SER GLU LYS SEQRES 2 C 60 TYR ALA PRO LEU ARG GLN LYS LEU LEU SER THR ASP ILE SEQRES 3 C 60 GLY SER VAL ALA SER PHE LEU LEU SER ARG GLU SER ARG SEQRES 4 C 60 ALA ILE THR GLY GLN THR ILE TYR VAL ASP ASN GLY LEU SEQRES 5 C 60 ASN ILE MET PHE LEU PRO ASP ASP SEQRES 1 D 60 TYR THR PHE ILE ASP TYR ALA ILE GLU TYR SER GLU LYS SEQRES 2 D 60 TYR ALA PRO LEU ARG GLN LYS LEU LEU SER THR ASP ILE SEQRES 3 D 60 GLY SER VAL ALA SER PHE LEU LEU SER ARG GLU SER ARG SEQRES 4 D 60 ALA ILE THR GLY GLN THR ILE TYR VAL ASP ASN GLY LEU SEQRES 5 D 60 ASN ILE MET PHE LEU PRO ASP ASP HET ZID B 450 52 HET ZID A 550 52 HETNAM ZID ISONICOTINIC-ACETYL-NICOTINAMIDE-ADENINE DINUCLEOTIDE FORMUL 5 ZID 2(C27 H30 N8 O15 P2) FORMUL 7 HOH *160(H2 O) HELIX 1 1 GLY A 110 ARG A 122 1 13 HELIX 2 2 TRP A 131 ASN A 144 1 14 HELIX 3 3 PHE A 147 MET A 151 1 5 HELIX 4 4 THR A 173 ILE A 177 5 5 HELIX 5 5 ASP A 178 ASN A 183 1 6 HELIX 6 6 THR A 194 GLY A 207 1 14 HELIX 7 7 ASP A 225 THR A 229 5 5 HELIX 8 8 SER A 230 SER A 242 1 13 HELIX 9 9 SER A 242 VAL A 253 1 12 HELIX 10 10 TYR A 267 GLN A 271 5 5 HELIX 11 11 GLY A 280 TYR A 303 1 24 HELIX 12 12 GLY B 110 ARG B 122 1 13 HELIX 13 13 TRP B 131 PRO B 133 5 3 HELIX 14 14 VAL B 134 ASN B 144 1 11 HELIX 15 15 PHE B 147 MET B 151 5 5 HELIX 16 16 THR B 173 ILE B 177 5 5 HELIX 17 17 ASP B 178 ASN B 184 1 7 HELIX 18 18 THR B 194 GLY B 207 1 14 HELIX 19 19 ASP B 225 THR B 229 5 5 HELIX 20 20 SER B 230 SER B 242 1 13 HELIX 21 21 SER B 242 VAL B 253 1 12 HELIX 22 22 TYR B 267 GLN B 271 5 5 HELIX 23 23 GLY B 280 ASN B 304 1 25 HELIX 24 24 SER B 317 ILE B 323 1 7 HELIX 25 25 TYR C 366 ALA C 380 1 15 HELIX 26 26 LEU C 387 SER C 400 1 14 HELIX 27 27 ARG C 401 ARG C 404 5 4 HELIX 28 28 GLY C 416 MET C 420 5 5 HELIX 29 29 TYR D 366 ALA D 380 1 15 HELIX 30 30 LEU D 387 SER D 400 1 14 HELIX 31 31 ARG D 401 ARG D 404 5 4 HELIX 32 32 GLY D 416 MET D 420 5 5 SHEET 1 A 7 ILE A 161 PRO A 166 0 SHEET 2 A 7 LYS A 125 ILE A 130 1 N ILE A 130 O LEU A 165 SHEET 3 A 7 ILE A 99 ILE A 105 1 N ILE A 102 O GLY A 129 SHEET 4 A 7 ILE A 209 HIS A 214 1 O VAL A 213 N ALA A 103 SHEET 5 A 7 MET A 256 THR A 266 1 O ILE A 263 N HIS A 214 SHEET 6 A 7 ARG A 306 ALA A 312 1 O ILE A 310 N SER A 264 SHEET 7 A 7 THR C 410 VAL C 413 1 O ILE C 411 N THR A 309 SHEET 1 B 2 ILE A 152 ILE A 153 0 SHEET 2 B 2 LYS A 157 LYS A 158 -1 O LYS A 157 N ILE A 153 SHEET 1 C 7 ILE B 161 PRO B 166 0 SHEET 2 C 7 LYS B 125 ILE B 130 1 N ILE B 130 O LEU B 165 SHEET 3 C 7 ILE B 99 ALA B 103 1 N ILE B 102 O GLY B 129 SHEET 4 C 7 ILE B 209 HIS B 214 1 O VAL B 213 N PHE B 101 SHEET 5 C 7 MET B 256 THR B 266 1 O ILE B 263 N HIS B 214 SHEET 6 C 7 ARG B 306 ALA B 312 1 O ILE B 310 N THR B 266 SHEET 7 C 7 THR D 410 VAL D 413 1 O ILE D 411 N THR B 309 SITE 1 AC1 30 GLY B 104 ILE B 105 GLY B 106 GLY B 110 SITE 2 AC1 30 TYR B 111 TRP B 131 PHE B 167 ASP B 168 SITE 3 AC1 30 ALA B 169 SER B 215 LEU B 216 ALA B 217 SITE 4 AC1 30 ASN B 218 LEU B 265 THR B 266 TYR B 267 SITE 5 AC1 30 LYS B 285 ALA B 312 GLY B 313 PRO B 314 SITE 6 AC1 30 LEU B 315 SER B 317 ALA B 319 HOH B 451 SITE 7 AC1 30 HOH B 462 HOH B 481 HOH B 493 HOH B 499 SITE 8 AC1 30 PHE D 368 ALA D 372 SITE 1 AC2 28 GLY A 104 ILE A 105 GLY A 106 GLY A 110 SITE 2 AC2 28 TYR A 111 TRP A 131 PHE A 167 ASP A 168 SITE 3 AC2 28 ALA A 169 SER A 215 LEU A 216 ALA A 217 SITE 4 AC2 28 ASN A 218 LEU A 265 THR A 266 TYR A 267 SITE 5 AC2 28 LYS A 285 GLY A 313 PRO A 314 LEU A 315 SITE 6 AC2 28 SER A 317 ALA A 319 ALA A 320 HOH A 556 SITE 7 AC2 28 HOH A 561 HOH A 570 PHE C 368 ALA C 372 CRYST1 131.899 131.899 82.845 90.00 90.00 90.00 P 43 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007582 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007582 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012071 0.00000 MASTER 286 0 2 32 16 0 15 6 0 0 0 46 END